{"id":403709,"date":"2021-11-05T01:33:50","date_gmt":"2021-11-05T08:33:50","guid":{"rendered":"https:\/\/nai500.com\/?p=403709"},"modified":"2021-11-05T01:33:50","modified_gmt":"2021-11-05T08:33:50","slug":"%e7%9b%98%e7%82%b9-11-%e6%9c%88%e5%80%bc%e5%be%97%e6%8a%95%e8%b5%84%e7%9a%84%e4%b8%89%e5%8f%aa%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80%e8%82%a1","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2021\/11\/%e7%9b%98%e7%82%b9-11-%e6%9c%88%e5%80%bc%e5%be%97%e6%8a%95%e8%b5%84%e7%9a%84%e4%b8%89%e5%8f%aa%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80%e8%82%a1\/","title":{"rendered":"\u76d8\u70b9\uff1a11\u6708\u503c\u5f97\u6295\u8d44\u7684\u4e09\u53ea\u751f\u7269\u79d1\u6280\u80a1"},"content":{"rendered":"<h2>\u5173\u952e\u70b9<\/h2>\n<ul>\n<li>\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u62e5\u6709\u591a\u5143\u5316\u7684\u4ea7\u54c1\u9635\u5bb9\u548c\u6709\u5438\u5f15\u529b\u7684\u4f30\u503c\u3002<\/li>\n<li>Exelixis\u7684\u764c\u75c7\u836f\u7269Cabometyx\u6709\u7ee7\u7eed\u5f3a\u52b2\u589e\u957f\u7684\u524d\u666f\u3002<\/li>\n<li>Vertex\u5728\u56ca\u6027\u7ea4\u7ef4\u5316\u9886\u57df\u5177\u6709\u5784\u65ad\u5730\u4f4d\uff0c\u800c\u4e14\u6709\u524d\u9014\u7684\u7ba1\u7ebf\u5019\u9009\u836f\u7269\u548c\u5927\u91cf\u73b0\u91d1\u50a8\u5907\u3002<\/li>\n<\/ul>\n<p>\u6709\u4e9b\u6295\u8d44\u51b3\u5b9a\u771f\u7684\u5f88\u96be\u505a\u51fa\u3002\u7136\u800c\uff0c\u5176\u4ed6\u7684\u51b3\u5b9a\u53ef\u80fd\u662f\u5feb\u901f\u800c\u7b80\u5355\u7684\u3002\u5f53\u80a1\u7968\u5177\u6709\u4e0d\u53ef\u5426\u8ba4\u7684\u5f15\u4eba\u6ce8\u76ee\u7684\u589e\u957f\u524d\u666f\u65f6\uff0c\u60c5\u51b5\u5c31\u662f\u5982\u6b64\u3002<\/p>\n<p>\u9009\u62e9\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\uff08NYSE:<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=BMY\">BMY<\/a>\uff09\u3001Exelixis\uff08NASDAQ:<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=EXEL\">EXEL<\/a>\uff09\u548cVertex Pharmaceuticals\uff08NASDAQ:<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=VRTX\">VRTX<\/a>\uff09\u7684\u539f\u56e0\u5982\u4e0b\uff1a<\/p>\n<h2>\u4ee5\u4f4e\u4f30\u503c\u4ea4\u6613\u3001\u62e5\u6709\u591a\u5143\u5316\u4e1a\u52a1<\/h2>\n<p>\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u6210\u4e3a\u4e00\u53ea\u5bb9\u6613\u88ab\u8bc1\u660e\u6709\u7406\u7531\u4e70\u5165\u7684\u80a1\u7968\u3002\u800c\u4e14\uff0c\u8be5\u516c\u53f8\u5728\u521a\u521a\u7ed3\u675f\u7684\u4e00\u4e2a\u8d22\u5b63\u8868\u73b0\u5f3a\u52b2\uff0c\u8fd9\u4f7f\u5f97\u8be5\u80a1\u770b\u8d77\u6765\u662f\u4e00\u4e2a\u66f4\u597d\u7684\u4ea4\u6613\u3002<\/p>\n<p>\u622a\u81f39\u670830\u65e5\uff0c\u8be5\u516c\u53f8\u516c\u5e03\u7684\u8c03\u6574\u540e\u6bcf\u80a1\u5229\u6da6\u4e3a2\u7f8e\u5143\uff0c\u8d85\u8fc7\u4e86\u5206\u6790\u5e08\u9884\u671f\u76841.92\u7f8e\u5143\u3002\u8fd9\u662f\u8be5\u533b\u7597\u4fdd\u5065\u516c\u53f8\u8fde\u7eed\u7b2c\u4e8c\u4e2a\u8d22\u5b63\u5b9e\u73b0\u4e86\u79ef\u6781\u7684\u76c8\u5229\u60ca\u559c\u3002\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u672c\u8d22\u5b63\u7684\u6536\u5165\u603b\u989d\u4e3a116\u4ebf\u7f8e\u5143\uff0c\u6bd4\u4e0a\u5e74\u540c\u671f\u589e\u957f\u4e8610%\u3002\u672c\u8d22\u5b63\u8fd8\u6709\u51e0\u4e2a\u4ea7\u54c1\u589e\u957f\u4e86\u81f3\u5c1110%\uff0c\u5305\u62ec\u5176\u6700\u7545\u9500\u7684\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u836f\u7269Revlimid\uff0c\u5e26\u6765\u4e8633\u4ebf\u7f8e\u5143\u7684\u6536\u5165\uff08\u540c\u6bd4\u589e\u957f11%\uff09\u3002<\/p>\n<p>\u867d\u7136\u4e00\u4e9b\u6295\u8d44\u8005\u53ef\u80fd\u62c5\u5fc3\u8be5\u516c\u53f8\u5931\u53bbRevlimid\u7684\u4e13\u5229\u4fdd\u62a4\uff0c\u4eff\u5236\u836f\u53ef\u80fd\u6700\u65e9\u5728\u660e\u5e74\u4e0a\u5e02\uff0c\u4f46\u8fd9\u662f\u6240\u6709\u533b\u7597\u4fdd\u5065\u516c\u53f8\u5c06\u4e0d\u53ef\u907f\u514d\u5730\u9762\u4e34\u7684\u95ee\u9898\u3002\u91cd\u8981\u7684\u662f\uff0c\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u591a\u5e74\u6765\u5728\u521b\u65b0\u65b9\u9762\u6709\u7740\u826f\u597d\u7684\u8bb0\u5f55\u3002<\/p>\n<p>\u5728\u8fc7\u53bb\u7684\u4e09\u4e2a\u8d22\u5b63\u91cc\uff0cRevlimid\u521b\u9020\u4e8695\u4ebf\u7f8e\u5143\u7684\u6536\u5165\uff0c\u5360\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u6536\u5165\u768428%\u3002\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u516c\u53f8\u62e5\u6709\u591a\u6837\u5316\u7684\u4e1a\u52a1\uff08\u5176\u76ee\u524d\u7684\u7ba1\u7ebf\u6d89\u53ca40\u591a\u4e2a\u75be\u75c5\u9886\u57df\u7684\u7814\u7a76\uff09\uff0c\u80fd\u591f\u7ecf\u53d7\u4f4f\u98ce\u66b4\u7684\u8003\u9a8c\u3002\u8fd9\u5c31\u662f\u4e3a\u4ec0\u4e48\u5b83\u662f\u4e00\u4e2a\u957f\u671f\u7684\u5b89\u5168\u9009\u62e9\u3002<\/p>\n<h2>\u4e00\u6b3e\u738b\u724c\u836f\u7269<\/h2>\n<p>\u80bf\u7624\u5b66\u9886\u57df\u5438\u5f15\u4e86\u4e00\u4e9b\u4e16\u754c\u4e0a\u6700\u5927\u7684\u5236\u836f\u548c\u751f\u7269\u79d1\u6280\u516c\u53f8\u3002\u4f46\u5373\u4f7f\u5728\u8fd9\u4e2a\u7ade\u4e89\u6fc0\u70c8\u7684\u5e02\u573a\u4e2d\uff0cExelixis\u4e5f\u8bbe\u6cd5\u4e3a\u81ea\u5df1\u5f00\u8f9f\u4e86\u4e00\u7247\u5929\u5730\u3002\u8fd9\u5bb6\u5236\u836f\u5546\u5e76\u4e0d\u662f\u4e00\u4e2a\u5bb6\u55bb\u6237\u6653\u7684\u540d\u5b57\uff0c\u4f46\u662f\u5b83\u7684\u8d22\u52a1\u4e1a\u7ee9\u5728\u8fc7\u53bb\u51e0\u5e74\u91cc\u4e00\u76f4\u5728\u7a33\u6b65\u63d0\u9ad8&#8211;\u8fd9\u8981\u5f52\u529f\u4e8e\u5b83\u7684\u65d7\u8230\u4ea7\u54c1Cabometyx\u3002<\/p>\n<p>Cabomextyx\u88ab\u6279\u51c6\u7528\u4e8e\u6cbb\u7597\u80be\u7ec6\u80de\u764c\uff08RCC\uff09\u548c\u809d\u7ec6\u80de\u764c\uff08HCC\uff09\u3002\u5728RCC\u4e2d\uff0c\u5b83\u662f\u540c\u7c7b\u836f\u7269\u4e2d\u7684\u7b2c\u4e00\u5904\u65b9\u836f\u3002\u5b83\u4e5f\u662f\u7b2c\u4e00\u4e2a\u5728\u4e09\u4e2a\u5173\u952e\u53c2\u6570\u4e0a\u53d6\u5f97\u663e\u8457\u6539\u5584\u7684\u836f\u7269\uff1a\u603b\u751f\u5b58\u671f\u3001\u65e0\u8fdb\u5c55\u751f\u5b58\u671f\u548c\u5ba2\u89c2\u53cd\u5e94\u7387\u3002<\/p>\n<p>Exelixis\u76ee\u524d\u6b63\u5728\u8fdb\u884c\u51e0\u5341\u9879Cabometyx\u7684\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4f5c\u4e3a\u72ec\u7acb\u6216\u8054\u5408\u6cbb\u7597\u8bb8\u591a\u5176\u4ed6\u5f62\u5f0f\u7684\u764c\u75c7\u3002\u968f\u7740\u8be5\u836f\u7269\u83b7\u5f97\u66f4\u591a\u7684\u6807\u7b7e\u6269\u5c55\uff0c\u8fd9\u5c06\u5bf9Exelixis\u4ea7\u751f\u6709\u610f\u4e49\u7684\u5f71\u54cd\u3002<\/p>\n<p>\u6211\u4eec\u5df2\u7ecf\u770b\u5230\u8fd9\u79cd\u60c5\u51b5\u53d1\u751f\u4e86\u3002\u4eca\u5e741\u6708\uff0cCabometyx\u4e0e\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u7684Opdivo\u4e00\u8d77\u88ab\u6279\u51c6\u4f5c\u4e3a\u665a\u671fRCC\u7684\u4e00\u7ebf\u8054\u5408\u6cbb\u7597\u3002\u7ed3\u679c\u5462\uff1f\u5728\u7b2c\u4e8c\u8d22\u5b63\uff0cCabometyx\u7684\u603b\u6536\u5165\u540c\u6bd4\u589e\u957f\u4e8659%\uff0c\u8fbe\u52302.756\u4ebf\u7f8e\u5143\u3002<\/p>\n<p>Cabometyx\u4f1a\u7ee7\u7eed\u53d6\u5f97\u8fdb\u5c55\u3002Exelixis\u8bbe\u5b9a\u7684\u76ee\u6807\u662f\uff0c\u5230\u660e\u5e74\u5e74\u5e95\uff0c\u8be5\u836f\u54c1\u7684\u5e74\u8fd0\u884c\u7387\u8fbe\u523015\u4ebf\u7f8e\u5143\u3002\u4f5c\u4e3a\u80cc\u666f\uff0c\u8be5\u751f\u7269\u79d1\u6280\u516c\u53f8\u57282020\u5e74\u7684\u603b\u6536\u5165\u4e3a9.875\u4ebf\u7f8e\u5143\u3002<\/p>\n<h2>\u4e00\u5982\u65e2\u5f80\u7684\u597d<\/h2>\n<p>\u73b0\u5728\u4f60\u5f88\u96be\u627e\u5230\u6bd4Vertex Pharmaceuticals\u66f4\u597d\u7684\u751f\u7269\u79d1\u6280\u3002\u8be5\u516c\u53f8\u5df2\u7ecf\u6709\u5f88\u9ad8\u7684\u76c8\u5229\u80fd\u529b\uff0c\u6536\u5165\u548c\u6536\u76ca\u90fd\u5728\u589e\u957f\uff0c\u5e76\u4e14\u8fd8\u62e5\u6709\u8bf1\u4eba\u7684\u589e\u957f\u524d\u666f\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u5f3a\u5927\u7684\u8d22\u52a1\u72b6\u51b5\u6e90\u4e8e\u5176\u56ca\u6027\u7ea4\u7ef4\u5316\uff08CF\uff09\u4e13\u8425\u6743\u3002Vertex Pharmaceuticals\u9500\u552e\u7684\u662f\u552f\u4e00\u80fd\u6cbb\u7597\u8fd9\u79cd\u9057\u4f20\u6027\u75be\u75c5\u6839\u672c\u539f\u56e0\u7684CF\u836f\u7269\u3002\u5c3d\u7ba1Vertex Pharmaceuticals\u5728\u56ca\u6027\u7ea4\u7ef4\u5316\u9886\u57df\u4eab\u6709\u5784\u65ad\u5730\u4f4d\uff0c\u4f46\u5b83\u4ecd\u6709\u5f88\u5927\u7684\u53d1\u5c55\u7a7a\u95f4\uff0c\u53ef\u4ee5\u8d62\u5f97\u66f4\u591a\u7684\u62a5\u9500\u4ea4\u6613\uff0c\u5e76\u83b7\u5f97\u5bf9\u6cbb\u7597\u5e74\u8f7b\u7fa4\u4f53\u7684\u6279\u51c6\u3002<\/p>\n<p>\u7ade\u4e89\u60c5\u51b5\u5982\u4f55\uff1f\u5f53\u7136\uff0c\u4e5f\u6709\u5c11\u6570\u5176\u4ed6\u516c\u53f8\u6b63\u5728\u5f00\u53d1CF\u836f\u7269\u3002\u7136\u800c\uff0c\u5b83\u4eec\u90fd\u8fd8\u6ca1\u6709\u8d85\u8fc72\u671f\u6d4b\u8bd5\u7684\u8fdb\u5ea6\u3002\u8fd9\u4f7fVertex Pharmaceuticals\u5728\u81f3\u5c11\u51e0\u5e74\u5185\u5904\u4e8e\u4ee4\u4eba\u7fa1\u6155\u7684\u5730\u4f4d\u3002<\/p>\n<p>\u540c\u65f6\uff0cVertex Pharmaceuticals\u6b63\u5728\u5bfb\u6c42\u6269\u5927CF\u7684\u8303\u56f4\u3002\u5b83\u5e0c\u671b\u80fd\u57282023\u5e74\u4e3aCTX001\u7533\u8bf7\u76d1\u7ba1\u6279\u51c6\uff0cCTX001 \u662f\u7f55\u89c1\u8840\u6db2\u75c5\u03b2-\u5730\u4e2d\u6d77\u8d2b\u8840\u75c7\u548c\u9570\u72b6\u7ec6\u80de\u75c5\u7684\u6cbb\u7597\u65b9\u6cd5\u3002Vertex Pharmaceuticals\u6b63\u5728\u4e0eCRISPR Therapeutics\u516c\u53f8\u5408\u4f5c\u5f00\u53d1\u8fd9\u79cd\u57fa\u56e0\u7f16\u8f91\u7597\u6cd5\u3002<\/p>\n<p>\u5982\u679cVertex Pharmaceuticals\u901a\u8fc7\u5546\u4e1a\u5f00\u53d1\u4ea4\u6613\u8fdb\u4e00\u6b65\u6269\u5927\u5176\u7ba1\u9053\uff0c\u8bf7\u4e0d\u8981\u611f\u5230\u60ca\u8bb6\u3002\u8be5\u751f\u7269\u79d1\u6280\u516c\u53f8\u7684\u73b0\u91d1\u50a8\u5907\u91cf\u5f88\u5927\uff0c\u800c\u4e14\u8fd8\u5728\u7ee7\u7eed\u589e\u957f\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u5173\u952e\u70b9 \u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u62e5\u6709\u591a\u5143\u5316\u7684\u4ea7\u54c1\u9635\u5bb9\u548c\u6709\u5438\u5f15\u529b\u7684\u4f30\u503c\u3002 Exelixis\u7684\u764c\u75c7\u836f\u7269Cabometyx\u6709\u7ee7\u7eed [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":403710,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[427],"tags":[455,925,459],"class_list":["post-403709","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hans","tag-455","tag-925","tag-459","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/403709","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=403709"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/403709\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/403710"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=403709"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=403709"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=403709"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}